magnesium trisilicate 14.2 MG
RxNorm concept 730999, clinical drug component (scdc).
- RxCUI
- 730999
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/730999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet (SCD, constitutes)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable] (SBD, constitutes)
- magnesium trisilicate (IN, has ingredient)
- aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG [Gaviscon Chewable] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 730999 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/730999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 730999. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.